BY ULRICH QUISTGAARD
-
Zealand Pharma appoints new development chief with experience from Novo Nordisk and FDA
Steven Johnson is worked with to lead growth at Zealand Pharma and originates from an SVP placement at UCB Biopharma.
-
Zealand Pharma appoints new development chief with experience from Novo Nordisk and FDA
Steven Johnson is hired to lead development at Zealand Pharma and comes from an SVP position at UCB Biopharma.
-
Leo Pharma and J&J join AI partnership funded by Innovation Fund Denmark
Development Fund Denmark has actually granted DKK 12.1 m to an AI collaboration called EVA to create an AI engine to enhance clinical therapies and spot negative effects much faste…
-
Merck downgrades earnings guidance due to geopolitical turmoil
Several sclerosis and cancer cells therapies have actually driven development in Merck’s life scientific research company, yet the business downgrades its full-year earnings …
-
Merck downgrades earnings guidance due to geopolitical turmoil
Multiple sclerosis and cancer treatments have driven growth in Merck’s life science business, but the company downgrades its full-year profit forecast, now targeting growth of roug…
-
Leo Pharma and J&J join AI partnership funded by Innovation Fund Denmark
Innovation Fund Denmark has awarded DKK 12.1m to an AI partnership called EVA to develop an AI engine to improve medical treatments and detect side effects faster.
-
Leo Pharma and J&J join AI partnership funded by Innovation Fund Denmark
Innovation Fund Denmark has awarded DKK 12.1m to an AI partnership called EVA to develop an AI engine to improve medical treatments and detect side effects faster.
-
What your attribution model isn’t telling you
The most effective online marketers do not simply track– they evaluate, model and maximize. Discover pointers for constructing a future-ready dimension structure.The message …
-
Pharmacosmos buys more cancer drug rights with acquisition
Lerociclib obstructs cell cycle development and can deal with different sorts of cancer cells, and the legal rights for growth and commercialization outside Asia-Pacific currently …
-
Roche to invest USD 50bn in US production expansion due to Trump’s tariff policy
Roche is purchasing brand-new manufacturing facilities in the states of Pennsylvania, Indiana, and Kentucky, to name a few, to develop work and advertise residential medication man…
